BrainCheck Appoints Kim Rodriguez as CEO

April 4, 2023 / Nueterra Capital Marketing

BrainCheck | A Nueterra Capital Portfolio Company

Nueterra Capital portfolio company BrainCheck has appointed veteran healthcare executive Kim Rodriguez as its new CEO, the company said in a press release. Rodriguez brings extensive experience in healthcare and health technology, including her prior roles as CEO at medical device company Halt Medical, leader of the Vascular Intervention Unit at Spectranetics (acquired by Royal Philips) and CEO and Co-Founder of Acessa Health, a venture-backed start-up focused on minimally invasive fibroid treatments. Prior to joining BrainCheck as CEO, Rodriguez was a venture partner at S3 Ventures, where she was active in the firm’s healthcare investments. At BrainCheck, Rodriguez’s leadership will empower the company’s growth. “She is a highly regarded leader with an excellent track record and extensive experience across healthcare, product development, and commercialization,” said BrainCheck Board Member and Next Coast Ventures General Partner Mike Smerklo. “Kim is uniquely positioned to lead the company as its growth accelerates.”